PAVmed
PAVM
91 hedge funds and large institutions have $80.7M invested in PAVmed in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 35 increasing their positions, 10 reducing their positions, and 9 closing their positions.
321% more capital invested
Capital invested by funds: $19.2M → $80.7M (+$61.5M)
289% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 9
250% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 10
40% more funds holding
Funds holding: 65 → 91 (+26)
0.02% more ownership
Funds ownership: 0.03% → 0.05% (+0.02%)
11% less call options, than puts
Call options by funds: $626K | Put options by funds: $702K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.37M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.68M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.94M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$2.09M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$686K |
| 2 |
VWM
Vigilare Wealth Management
Scottsdale,
Arizona
|
-$283K |
| 3 |
JP Morgan Chase
New York
|
-$259K |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$233K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$161K |
PAVM Hedge Fund Activity: Q1 2021 in Review
91 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2021, worth a combined $80.7M — up 321% from $19.2M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new PAVM positions and 9 closed out — a net gain of 26 holders — while 35 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $8.37M. The largest seller was Belpointe Asset Management, cutting an estimated $686K.
- 91 institutional investors held PAVmed (PAVM) as of Q1 2021, up from 65 in Q4 2020.
- Funds reported $80.7M of PAVmed stock for Q1 2021, up 321% quarter-over-quarter.
- 35 funds opened new PAVmed positions in Q1 2021 and 9 closed out, a net change of +26 holders.
- The largest PAVmed buyer in Q1 2021 was BlackRock, an estimated $8.37M added.
- The largest PAVmed seller in Q1 2021 was Belpointe Asset Management, an estimated $686K sold.
Based on aggregated 13F filings for Q1 2021.